Skyhawk Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Skyhawk Therapeutics

Access the complete profile.

Skyhawk Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	77 4th Ave Suite 340 Waltham, MA 02451

Note: Revenues for privately held companies are statistical evaluations.


Skyhawk Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Skyhawk Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Skyhawk Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Skyhawk Therapeutics Annual Revenue and Growth Rate

Skyhawk Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Skyhawk Therapeutics's revenues are gauged from an analysis of company filings.

Skyhawk Therapeutics's Income Statement (based on Industry Averages)

Skyhawk Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Skyhawk Therapeutics is developing and marketing. Skyhawk Therapeutics doesn't have any recent trademark applications, indicating Skyhawk Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SKYSTAR Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression, used in the treatment of cancers, neurological diseases, and other diseases, namely, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders and fibrosis; pharmaceuticals used in the treatment of cancers, neurological diseases, and other diseases, namely, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders and fibrosis	03/17/2022
SKY-SEQ Research and development of pharmaceuticals, namely, small molecule therapies for the alteration of RNA splicing and expression, used in the treatment of cancers, neurological diseases, infectious diseases and other diseases using integrated and high-throughput screening technologies coupled with next-generation sequencing	03/19/2021

See all trademarks and details in the Full Report.

Market Share of Skyhawk Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Skyhawk Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Skyhawk Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ELEVATEBIO IPSC	Waltham, MA	100
IMMUNOGEN	Waltham, MA	36
BOSTON IVF	Waltham, MA	34
NPS PHARMACEUTICALS	Lexington, MA	32
CLINICAL SERVICES CORPORATE OPERATIONS	Waltham, MA	20
FOSTER-MILLER	Waltham, MA	15

Other Companies at 77 4th Ave, Waltham MA

Company	Headquarters	Revenue ($ MM)
ROCKET SOFTWARE	Waltham, MA	100
RSD AMERICA	Waltham, MA	1
ASG FEDERAL	Waltham, MA	0

Future Competition: Skyhawk Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Skyhawk Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)